| Literature DB >> 31366184 |
Magdalena Zgliczynska1, Iwona Szymusik2, Aleksandra Sierocinska1, Armand Bajaka1, Martyna Rowniak1, Nicole Sochacki-Wojcicka3, Miroslaw Wielgos3, Katarzyna Kosinska-Kaczynska3.
Abstract
The aim was to evaluate contraceptive behaviors, and factors affecting them, in the population of Polish-speaking women. A cross-sectional study was performed on 6763 women, current contraceptive users, aged 18 to 35. An anonymous and voluntary questionnaire written in Polish, containing 33 questions, was distributed online from January to February 2017. The Internet and doctors were the most popular sources of information about contraception (82% and 73%, respectively). Upon choosing contraception, women paid the most attention to its efficacy (85%) and its impact on health (59%). The most common methods were combined oral contraceptives (38%) and condoms (24%). In total, 51% had chosen hormonal contraception, of which 68% experienced side effects. The most frequent were decreased libido (39%) and weight gain (22%). Factors associated with the usage of hormonal or non-hormonal contraception were: education, relationship status, parenthood, number of sexual partners, frequency of intercourses, sources of information about contraception, and factors considered most important when choosing a contraceptive method. The choice between short-acting and long-acting reversible contraception was influenced by age, relationship status, parenthood, smoking, sources of information about contraception, and factors considered most important when choosing a contraceptive method. Wide access to contraception, high-quality education, and counselling should become priorities in family planning healthcare.Entities:
Keywords: contraception; contraception methods; contraceptive counselling; family planning; reproductive health
Mesh:
Substances:
Year: 2019 PMID: 31366184 PMCID: PMC6695758 DOI: 10.3390/ijerph16152723
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of the study population.
| Variable | % (n) |
|---|---|
|
| |
| 26.4 (average) | standard deviation 3.9 |
| 18–24 | 34% (n = 2268) |
| 25–29 | 44% (n = 2955) |
| 30–35 | 23% (n = 1540) |
|
| |
| Primary | <1% (n = 43) |
| Secondary | 29% (n = 1950) |
| Vocational | 1% (n = 75) |
| Higher | 69% (n = 4695) |
|
| |
| Rural and city < 5000 inhabitants | 20% (n = 1324) |
| City 5000–200,000 inhabitants | 35% (n = 2368) |
| City 200,000–1,000,000 inhabitants | 30% (n = 2000) |
| City > 1,000,000 | 16% (n = 1071) |
|
| |
| <1000 PLN (~0–230 EUR) | 17% (n = 1167) |
| >1000–2500 PLN (~230–580 EUR) | 53% (n = 3596) |
| >2500–3500 PLN (~580–815 EUR) | 16% (n = 1075) |
| >3500 PLN (>815 EUR) | 14% (n = 925) |
|
| |
| Married | 49% (n = 3312) |
| Informal relationship | 46% (n = 3119) |
| Single | 5% (n = 332) |
|
| |
| No children | 60% (n = 4080) |
| One child | 27% (n = 1806) |
| Two or more children | 13% (n = 877) |
|
| |
| Few times a week | 18% (n = 1200) |
| Once a week | 13% (n = 900) |
| Occasionally | 55% (n = 3709) |
| Not at all | 14% (n = 954) |
|
| |
| Yes, regularly | 10% (n = 703) |
| Yes, occasionally | 9% (n = 635) |
| Not at all | 80% (n = 5425) |
|
| |
| Thyroid diseases | 13% (n = 867) |
| Asthma | 2% (n = 143) |
| Diabetes or prediabetes | 1% (n = 86) |
| Hypertension | <1% (n = 51) |
Contraceptive methods used by the study population.
| Contraception Method | |
|---|---|
| Condoms in total * | 50% (n = 3375) |
| COCs ** | 38% (n = 2586) |
| Condoms only | 24% (n = 1642) |
| Withdrawal | 17% (n = 1171) |
| Natural family planning | 13% (n = 897) |
| Vaginal ring | 4% (n = 263) |
| Transdermal patch | 3% (n = 202) |
| Progestogen-only pills | 2% (n = 163) |
| Hormonal IUD *** | 2% (n = 142) |
| Copper IUD | 2% (n = 105) |
| Implant | <1% (n = 54) |
| Medroxyprogesterone injection | <1% (n = 16) |
| Female condom | <1% (n = 13) |
| Vasectomy | <1% (n = 3) |
* combined with other methods; ** combined oral contraceptives; *** intrauterine device.
Results of the multiple logistic regression of factors associated with the use of hormonal contraception.
|
|
|
|
|
| ||
| Primary/Secondary/Vocational | 1.18 (1.04; 1.33) | 0.009 |
| Higher | 1.00 (reference) | - |
|
| ||
| Single | 1.00 (reference) | - |
| Informal relationship | 0.56 (0.42; 0.76) | <0.001 |
| Married | 0.32 (0.24; 0.44) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.60 (0.52; 0.68) | <0.001 |
|
| 1.02 (1.00; 1.04) | 0.015 |
|
| 1.12 (1.06; 1.19) | <0.001 |
|
| ||
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.66 (0.57; 0.76) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 2.87 (2.52; 3.27) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.66 (0.59; 0.75) | <0.001 |
|
| ||
| No | 1.00 (ref.) | - |
| Yes | 1.30 (1.15; 1.47) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.77 (0.68; 0.86) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.55 (0.45; 0.68) | <0.001 |
|
| ||
|
| - | |
| No | 1.00 (reference) | |
| Yes | 2.12 (1.79; 2.52) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.33 (0.29; 0.37) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 1.34 (1.13; 1.59) | 0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.19 (0.13; 0.28) | <0.001 |
* adjusted odds ratio (95% confidence interval).
Results of the multiple logistic regression of factors associated with the use of long-acting reversible contraceptives (LARCs).
| Factor | aOR (95% CI) * | |
|---|---|---|
|
| 1.07 (1.03; 1.11) | <0.001 |
|
| ||
| Single | 1.00 (reference) | - |
| Informal relationship | 0.49 (0.29; 0.84) | 0.01 |
| Married | 0.38 (0.22; 0.67) | 0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 4.69 (3.43; 6.41) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Occasionally | 1.29 (0.86; 1.93) | 0.224 |
| Yes | 1.75 (1.26; 2.45) | 0.001 |
|
| ||
|
| ||
| No | 1.00 (reference) | - |
| Yes | 1.39 (1.02; 1.88) | 0.035 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.73 (0.56; 0.96) | 0.024 |
|
| ||
|
| ||
| No | 1.00 (reference) | |
| Yes | 1.93 (1.28; 2.90) | 0.002 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 2.63 (2.06; 3.36) | <0.001 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.45 (0.27; 0.74) | 0.002 |
|
| ||
| No | 1.00 (reference) | - |
| Yes | 0.21 (0.05; 0.87) | 0.032 |
* adjusted odds ratio (95% confidence interval).
Chances of achieving satisfaction with current contraceptive method with condoms only as a reference.
| Satisfaction with Applied Method | ||||||
|---|---|---|---|---|---|---|
| Method | Yes | No | ||||
| n | % | n | % | OR (95%CI) * | ||
| Condoms only (n = 1642) | 1401 | 85% | 241 | 15% | 1.00 (reference) | - |
| Withdrawal only (n = 261) | 232 | 89% | 29 | 11% | 1.38 (0.91–2.07) | 0.125 |
| Natural family planning only (268) | 260 | 97% | 8 | 3% | 5.59 (2.73–11.45) | <0.001 |
| COCs ** only (n = 1807) | 1679 | 93% | 128 | 7% | 2.26 (1.80–2.83) | <0.001 |
| Vaginal ring only (n = 224) | 215 | 96% | 9 | 4% | 4.11 (2.08–8.12) | <0.001 |
| Transdermal patch only (n = 168) | 149 | 89% | 19 | 11% | 1.35 (0.82–2.22) | 0.2359 |
| Progesterone-only pills only (n = 134) | 110 | 82% | 24 | 18% | 0.79 (0.50–1.25) | 0.1951 |
| Hormonal IUD *** only (n = 131) | 129 | 98% | 2 | 2% | 11.10 (2.73–45.14) | <0.001 |
* odds ratio (95% confidence interval); ** combined oral contraceptives; *** intrauterine device.
Risk of decreased libido, weight gain and mood disorders for selected contraceptives in comparison with combined oral contraceptives (COCs) as reference.
| Side Effects Methods | Yes | No | ||||
|---|---|---|---|---|---|---|
| n | % | n | % | OR (95%CI) * | ||
|
| ||||||
| COCs ** (n = 2586) | 941 | 36% | 1645 | 64% | 1.00 (reference) | - |
| Vaginal ring (n = 263) | 103 | 39% | 160 | 61% | 1.13 (0.87–1.46) | 0.374 |
| Transdermal patch (n = 202) | 72 | 36% | 130 | 64% | 0.97 (0.72–1.31) | 0.832 |
| Progestogen-only pills (n = 163) | 56 | 34% | 107 | 66% | 0.91 (0.66–1.28) | 0.601 |
| Hormonal IUD *** (n = 142) | 23 | 16% | 119 | 84% | 0.34 (0.21–0.53) | <0.001 |
|
| ||||||
| COCs (n = 2586) | 617 | 24% | 1969 | 76% | 1.00 (reference) | - |
| Vaginal ring (n = 263) | 46 | 17% | 217 | 83% | 0.68 (0.49–0.94) | 0.020 |
| Transdermal patch (n = 202) | 51 | 25% | 151 | 75% | 1.08 (0.77–1.50) | 0.656 |
| Progestogen-only pills (n = 163) | 34 | 21% | 129 | 79% | 0.84 (0.57–1.24) | 0.382 |
| Hormonal IUD (n = 142) | 10 | 7% | 132 | 93% | 0.24 (0.13–0.46) | <0.001 |
|
| ||||||
| COCs (n = 2586) | 611 | 24% | 1975 | 76% | 1.00 (reference) | - |
| Vaginal ring (n = 263) | 34 | 13% | 229 | 87% | 0.48 (0.33–0.70) | <0.001 |
| Transdermal patch (n = 202) | 29 | 14% | 173 | 86% | 0.54 (0.36–0.81) | 0.003 |
| Progestogen-only pills (n = 163) | 27 | 17% | 136 | 83% | 0.64 (0.42–0.98) | 0.038 |
| Hormonal IUD (n = 142) | 12 | 8% | 130 | 92% | 0.30 (0.16–0.54) | <0.001 |
* odds ratio (95% confidence interval); ** combined oral contraceptives; *** intrauterine device.